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Objective: In obesity, the excessive adipose tissue increases the synthesis of inﬂammatory
cytokines,  which appear to alter the metabolism of minerals, such as zinc. However, the
mechanisms  involved remain unclear. This study investigated whether the concentrations
of  interleukin-6 (IL-6) and tumor necrosis factor- (TNF-) in plasma can to inﬂuence bio-
chemical  parameters of zinc in obese women.
Methods: Seventy-six pre-menopausal women, aged between 20 and 50 years, were divided
into  two groups: the case group, composed of obese women (n = 37) and the  control group,
composed  of non-obese women (n = 39). Analysis of the plasmatic and erythrocytary zinc,
and  plasmatic cytokines were conducted by  ﬂame atomic absorption spectrophotometry
and  by ELISA, respectively.
Results:  The plasmatic zinc and concentrations of IL-6 in plasma did not show signiﬁ-
cant  differences between obese women and controls (p > 0.05). The erythrocytary zinc was
36.4  ± 15.0 g/gHb in the case group, and 45.4 ± 14.3 g/gHb (p = 0.025) in the control group.
The  concentrations of TNF- in plasma were 42.0 ± 11.9 pg/mL and 19.0 ± 1.0 pg/mL in obese
women  and in controls, respectively (p < 0.001). The plasmatic zinc had a signiﬁcant negative
correlation with the values of TNF (r = −0.44, p = 0.015).
Conclusion:  Obese women presented lower concentrations of erythrocytary zinc than the
control  group. The study demonstrated a  probable inﬂuence of the inﬂammatory process
on  metabolism of zinc in obese patients.
© 2013 Elsevier Editora Ltda.  
Concentrac¸ões  plasmáticas  de IL-6  e  TNF-  e  sua  relac¸ão  com  a zincemia
em  mulheres  obesas
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Objetivo: Na obesidade, o  excesso de tecido adiposo aumenta a  síntese de  citocinas inﬂa-
matórias  que parecem alterar o metabolismo de minerais, como o zinco. Entretanto, os
mecanismos  envolvidos neste processo ainda não estão totalmente esclarecidos. O  estudo
 Study conducted at the Department of Nutrition, Universidade Federal do Piauí, Teresina, PI, Brazil.
∗ Corresponding author.
E-mail:  dilina.marreiro@gmail.com (D.N. Marreiro).
-4 ©  2013 Elsevier Editora Ltda. 2255 823
Este é um artigo Open Access sob a licença de CC BY-NC-ND
Este é um artigo Open Access sob a licença de CC BY-NC-ND
430  r  e  v a s  s  o  c  m e  d b  r  a s . 2 0 1 3;5 9(5):429–434
Inﬂamac¸ão
Interleucina-6
Fator de necrose tumoral-
investigou se as concentrac¸ões  de  interleucina-6 (IL-6) e fator de necrose tumoral- (TNF-)
no plasma podem inﬂuenciar os parâmetros bioquímicos do zinco.
Métodos:  Setenta e três mulheres, com idade entre 20  e 50  anos, foram distribuídas em
dois grupos: grupo caso, composto de  obesas (n = 37) e grupo controle, composto de  não
obesas (n = 39). Análises de  zinco plasmático e eritrocitário e as  citocinas inﬂamatórias plas-
máticas foram realizadas pelo método da espectrofotometria de  absorc¸ão  atômica e  pelo
ELISA, respectivamente.
Resultados: O  zinco plasmático e  as concentrac¸ões  de IL-6 no plasma não mostraram
diferenc¸as  signiﬁcativas entre as  mulheres obesas e grupo controle (p > 0,05). O  valor do
zinco eritrocitário foi 36,4 ± 15,0 g/gHb nas mulheres obesas e 45,4 ± 14,3 g/gHb (p = 0,025)
no grupo controle. As concentrac¸ões  de  TNF- no plasma foram 42,0 ± 11,9 pg/mL e
19,0 ± 1,0 pg/mL nas mulheres obesas e controles, respectivamente (p < 0,001). O zinco plas-
mático apresentou uma correlac¸ão  negativa signiﬁcativa com os valores de TNF- (r = −0,44,
p = 0,015).
Conclusão: As mulheres obesas apresentaram menores concentrac¸ões  de  zinco eritrocitário
em relac¸ão  ao grupo controle. O estudo mostra uma provável inﬂuência do  processo inﬂa-
matório no metabolismo do zinco em pacientes obesos.
©  2013 Elsevier Editora Ltda. 
Introduction
Obesity is  directly related to changes in the  endocrine and
metabolic functions of adipose tissue. In obese individuals,
this tissue increases the capacity for synthesis of adipocy-
tokines  or adipokines with proinﬂammatory action. Studies
have  identiﬁed that metabolic disturbances in obesity are
related  to macronutrient levels. Recently, there has been an
increased  interest on the contribution of minerals in various
pathophysiological changes associated with obesity.1–3
Zinc is one of the most important minerals for metabolism.
Among its biological functions, this element is a  cofactor of
over  300 metalloenzymes; it acts in  the catalytic activity of
several  enzymes, such as  carbonic anhydrase, alcohol dehy-
drogenase,  alkaline phosphatase, and enzymes involved in the
metabolism  of carbohydrates, lipids, and proteins.4,5
Tissues of obese animals have low concentrations of
micronutrients, such as zinc, copper, iron, and manganese.
Kennedy and Failla6 observed low concentrations of zinc in
the skin, muscle, pancreas, and bone of obese mice. Moreover,
the  liver, intestine, and adipose tissues had higher zinc con-
centrations, suggesting a  possible change in  the distribution
of  the mineral in the obese.
A  relationship between zinc status and cytokine pro-
duction is reported in disorders associated with chronic
inﬂammation, such as obesity. This process may  occur
through an increase in  the content of hepatic zinc at the
expense  of plasmatic zinc. Elevated concentrations of gluco-
corticoids  lead to a reduction of plasmatic zinc and an increase
in  zinc uptake by the liver. These data show the involvement of
synergistic  participation of interleukin-6 (IL-6), tumor necrosis
factor-  (TNF-), and glucocorticoids on the metabolic behav-
ior  of zinc; the combination of these elements depend on an
adequate  zinc content in the liver.7,8
In humans, inﬂammatory cytokines have been demon-
strated  to both up- and down-regulate the expression of
speciﬁc  cellular zinc transporters (ZnT’s and Zip’s), in response
to  an increasing demand for zinc in inﬂammation.9,10 In these
processes, there is  an increase of expression of encoding
genes  for zinc-transporter protein Zip-14, which promotes the
uptake  of zinc from the extracellular compartment to
the  interior of the cells. In obesity, a  high concentration of IL-6
in  plasma promotes an increase in gene expression of this
transporter, which may  alter the distribution of zinc in  cel-
lular  compartments.7,11 Studies have demonstrated a  rapid
decrease  in zinc plasma concentration that was  preceded by
prominent increases in concentration of TNF- and IL-6 in
plasma  in humans exposed to inﬂammation.9,12,13
Considering the importance of obesity as  a chronic disease,
the  secretion of adipocytokines and other proteins in the adi-
pose  tissue, and the  possible inﬂuence of these metabolites
on  the homeostasis of zinc, this study aimed to investigate
the  relationship between biochemical parameters of zinc and
the  concentrations of IL-6 and of TNF- in the plasma of obese
women.
Methods
This was a clinical and case-control study, involving 76  ran-
domly  selected adult females, aged between 20 and 50 years,
who  sought treatment at an endocrinology clinic. This sam-
ple  derived from the study by Ferro et al.14 The analysis of
concentrations of proinﬂammatory cytokines in  plasma was
performed  from a  biobank of samples arising from the afore-
mentioned research,14 developed in the Universidade Federal
do  Piauí (UFPI) by researchers involved in this study.
The  obese women  (n  = 37) who presented at the clinic were
selected  for the study if they met  the following criteria: their
body  mass index (BMI) was higher than 30 kg/m2; they were
not  taking any vitamin-mineral supplementation and/or other
medicines; they did not have any illnesses that could inter-
fere  with zinc-related nutritional status and metabolic proﬁle,
such as diabetes mellitus, chronic renal insufﬁciency, chronic
diarrhea, and malabsorption syndrome; and were  nonsmok-
ers.  The control group (n = 39) was  selected according to the
same  criteria as the obese women, but had a  BMI  between
18.5 kg/m2 and 24.9 kg/m2.  The study was approved by the
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Ethics Committee of the UFPI, and the individuals signed an
informed  consent.
Assessment  of  nutritional  status
BMI  was  calculated using measures of weight in kilograms and
height  in meters. The classiﬁcation of obesity according to BMI
was conducted in agreement with the criteria of the World
Health  Organization.15
Collection  of  biological  material  and  biochemical
parameters
Blood samples (25 mL)  were taken in the morning, from
7:30  am to  9:00 am,  after at least a 12-hour fast. The plasma
was  separated from the total blood by centrifugation at
1,831  xg  for 15 minutes at 4 ◦C (SIGMA 2K15 centrifuge). Three
aliquots  of each plasma sample were  diluted at a ratio of 1:4
with  Milli-Q® water and aspirated directly into the  ﬂame of the
atomic  absorption spectrophotometer.16 Tryptizol® (Merck),
prepared by dilution with Milli-Q® water with 3% glycerol
at  0.1, 0.2, 0.3, 0.5, and 1.0 g/mL dilutions were used as a
standard.
For  the separation of the erythrocytes, the erythrocytary
mass obtained from total blood was  washed three times with
5  mL of 0.9% saline solution, homogenized by inversion, and
centrifuged  at 2,493 xg for 10 minutes (Sorvall® RC-SB) at 4 ◦C.
After  the last centrifugation, the saline solution was  aspirated,
and  the erythrocytary mass was  carefully extracted using
a  micropipette, placed in demineralized Eppendorf tubes,
and  stored at −20 ◦C for zinc and hemoglobin analysis.17 To
express  the results in  terms of mass zinc/mass of hemoglobin
(g/gHb),  the erythrocytary lysis was  measured according to
the  cyanmethemoglobin method.18
The erythrocyte analysis was  performed using atomic
absorption spectrophotometry.12 Tryptizol® was  used as  a
reference, prepared by dilution in  Milli-Q® water at concentra-
tions  of 0.1, 0.2, 0.3, 0.5, and 1.0 g/mL. The reference interval
for  plasmatic and erythrocytary zinc is 70-110 g/dL and 40-
44  g/gHb, respectively.19,20
The concentrations of IL-6 and of TNF- in plasma were
performed by enzyme linked immunosorbent assay (ELISA),
using  the Lincoplex Cytokine Analytes Kit (Linco Research -
Missouri, USA), according to  the methodology recommended
by  the manufacturer. The limits of detection for IL-6 and TNF-
were  0.3 to 0.7 pg/mL and 0.1 pg/mL, respectively.
Statistical  analysis
Data were  processed and analyzed using the  S-PLUS software
for  Windows, version 3.2, and Minitab Release, version 11.0 for
Windows 9.0. Student’s t-test and Mann-Whitney tests were
used to determine whether differences on the main study vari-
ables  existed between groups. Pearson’s correlation analysis
was  applied to establish the correlation of concentrations of
IL-6  and TNF- in  plasma with the plasmatic and erythrocy-
tary  zinc. Signiﬁcance was  established at p < 0.05 a priori for all
statistical  tests.
Results
The subject’s characteristics are shown in Table 1. In this study,
a  signiﬁcant difference between the case and control groups
was  observed regarding erythrocytary zinc and the  plasmatic
TNF-,  as  demonstrated in  Table 2, and a signiﬁcant nega-
tive  correlation between plasmatic zinc and TNF- in obese
patients (r = −0.44, p = 0.015), shown in Table 3 and Fig. 1.
Discussion
There was no statistically signiﬁcant difference between both
groups  (p > 0.05) regarding mean concentrations of zinc in
plasma.  It is worth noting that the plasma is  a parameter of
zinc  that has  a  fast dynamic, constantly under homeostatic
control, which may  change in response to certain condi-
tions,  such as  stress, infection, hormonal action, and food
intake.21,22 These factors may  have inﬂuenced the results of
plasmatic zinc found in this study.
Another important aspect is that, in the  bloodstream, 80%
of  zinc is  present in the  erythrocytes and only 16% is  found
in  plasma. Since the half-life of erythrocytes is 120 days,
erythrocytary zinc appears to be  a parameter that assesses
the  nutritional status of this trace element with higher
sensitivity.23 Thus, unlike the results obtained in plasma,
the mean values of erythrocytary zinc in the obese women
were  signiﬁcantly lower than in the controls. The data are
Table 1 – Subjects characteristics.
Parameters Obese women Mean ± SD Control Mean ±  SD p
Age (years) 33.7 ± 7.89 31.2 ± 7.82 0.79
Weight (kg) 82.6* ± 11.40 54.4* ± 5.4 0.01
Height (cm)  154.3 ± 0.05 157.6 ± 0.06 0.52
BMI (kg/m2)  34.5* ± 3.40 21.7* ± 1.90 0.001
WC (cm) 102.4* ± 8.50 75.4* ± 6.30 0.04
BMI, body mass index; WC, waist  circumference.
∗ Values statistically signiﬁcant between the  obese women and the
control group, Student’s t- test (p < 0.05).
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Fig. 1  – Correlation analysis between plasmatic zinc and
concentration of TNF- in plasma in  obese women. n = 37,
r = −0.44, p = 0.015.
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Table 2 – Plasma and erythrocytary zinc, and plasma concentrations of IL-6 and of TNF-. Values are means standard
deviation.
Parameters Obese women Mean ± SD  Control Mean ± SD  p
Plasma zinc (g/dL) 72.2 ± 9.0 73.4 ± 8.5 0.48
Erythrocytary zinc (g/gHb) 36.4a ± 15.0 45.4*  ± 14.3 0.025
IL-6 (pg/mL) 76.38 ± 45.00 73.65 ± 27.10 0.76
TNF- (pg/mL) 42.02b ± 11.91 18.98b ± 0.97 0.001
IL-6,  interleukin 6; TNF-, tumor necrosis factor-.
a Values signiﬁcantly different between the obese women and the control group, student T test (p <  0.05).
b Values statistically signiﬁcant between the  obese women and the control group, Mann-Whitney test  (p < 0.05).
Table 3 – Correlation analysis results for concentration of proinﬂammatory cytokines IL-6 and TNF- in plasma and
biochemical parameters of zinc in  obese women.
Parameters Plasma Zn Erythrocytary Zn
Correlation coefﬁcient (r) p Correlation coefﬁcient (r) p
IL-6 (pg/mL) −0.30  0.082 0.11 0.526
TNF- (pg/mL) −0.44a 0.015 −0.17 0.372
r, correlation coefﬁcient; IL-6, interleukin 6; TNF-, tumor necrosis factor-; Zn, zinc.
a Values statistically signiﬁcant between the  obese women and the control group, student T  test  (p  < 0.05).
consistent with those found by Marreiro, Fisberg, Cozzolino24
and by Ozata et al.25
The compartmentalization and metabolism of zinc in
obesity  have been extensively investigated. In the study by
Begin-Heick  et al.,26 elevated zinc concentrations were found
in  the adipose tissue, liver, and muscle of obese mice. Accord-
ing  to the authors, high concentrations of hormones, such as
glucocorticoids, stimulate the synthesis of metallothionein, a
protein that acts in the transportation and retention of zinc in
some tissues.
Some mechanisms responsible for the compartmental-
ization of zinc in obese individuals are reported, such as
the  inﬂuence of zinc-transporter proteins and of the inﬂam-
matory  process. Schmidt et al.27 assessed the expression of
zinc-transporter proteins, from the Zips and ZnTs families, in
visceral and subcutaneous adipose tissue of obese patients,
and  it was  observed that most of these proteins are expressed
at  a higher level in subcutaneous adipose tissue. According
to  the authors, the  high gene expression of zinc-transporter
proteins suggests that obesity can inﬂuence the  system that
transports  this mineral in  adipose tissue, favoring the mani-
festation  of hypozincemia in obese individuals. However, the
possible  mechanisms involved are still unclear.
Some studies indicate the involvement of pro-
inﬂammatory cytokines secreted by adipocytes in alterations
often  found in  the metabolic behavior of zinc in obese
patients. It is  currently understood that adipose tissue, in
addition  to its function of storing energy reserves in the
form  of triglycerides, is an  endocrine organ capable of pro-
ducing  several hormones and signaling molecules known as
adipocytokines or adipokines. IL-6, IL-8, and TNF-, secreted
by  adipose tissue, are molecules that have pro-inﬂammatory
function, and are found in high concentrations in  obese
subjects.1,28
The mean concentrations of pro-inﬂammatory adipokine
IL-6  in plasma did not have a statistically signiﬁcant difference
between  groups. However, Piva et  al.29 found elevated concen-
trations  of IL-6 in  obese patients. The discrepancy observed in
these results can be attributed to  the sensitivity in  the protocol
used  to analyze these cytokines.
Unlike  the results of IL-6, the plasma concentrations of
TNF-  in the obese women were higher than in  the con-
trol  group. These results are similar to those found by Park
et  al.30 and by Winkler et  al.31 in obese patients. The impact of
the  secretion of proinﬂammatory adipokines in adipocytes on
metabolic disorders associated with obesity (such as insulin
resistance,  heart diseases, and liver diseases) has been widely
demonstrated.
To  better understand zinc metabolism in  obese patients,
the inﬂuence of inﬂammatory markers on the concentration
of  zinc in plasma was  investigated. Although the plasmatic
zinc was not different between the groups, there was  a signiﬁ-
cant  negative correlation between the  concentrations of TNF-
in  plasma and plasmatic zinc (r  = −0.44, p = 0.015). Accord-
ing  to Cousins et  al.,7 TNF- is a  proinﬂammatory cytokine
capable of stimulating the expression of encoding genes for
zinc-transporter protein, such as  Zip-14 and Zip-6, which con-
tribute  to the inﬂux of zinc to the cells and speciﬁc tissues,
causing  a  reduction of this mineral in blood components.
Other studies that investigated the existence of a neg-
ative  association between pro-inﬂammatory markers and
biochemical parameters of zinc suggest that this mineral is  an
important tool in the control of the expression of inﬂamma-
tory cytokines. Zinc supplementation stimulates the synthesis
of  A-20 protein, which, in turn, contributes to  reducing the
activation  of the signaling pathway of nuclear factor kappa
,  preventing the synthesis and secretion of TNF- and other
pro-inﬂammatory cytokines.32,33
Considering the complexity of the mechanisms involved
in the changes of the  behavior of mineral metabolism in
obese  patients, and the likely inﬂuence of pro-inﬂammatory
adipokines in these alterations, further studies on the role of
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these molecules in the distribution of zinc in obese individuals
may  contribute to a  better understanding of the issue.
It  is important to  highlight the speciﬁcity and sensitivity
of  the kits used to analyze the  inﬂammatory cytokines IL-6
and  TNF-, which certainly compromised the consistency of
the  data in this study. This discussion is also based on the
absence  of a homeostatic control of these substances, because
the  synthesis of cytokines is inﬂuenced by several factors, such
as acute or chronic subclinical inﬂammation, which probably
inﬂuenced the results found in this study.
Conclusion
The obese women  evaluated in  this study presented lower ery-
throcytary zinc levels than the control group. Furthermore,
the  analysis of the correlation between pro-inﬂammatory
cytokines and biochemical parameters of zinc only achieved
statistical signiﬁcance in relation to TNF- - this molecule has
a  negative correlation with plasmatic zinc. This result sug-
gests  a  probable inﬂuence of the inﬂammatory process on the
metabolism  of zinc in  obese patients. However, the inconsis-
tent  results of studies on the subject reinforce the need for
further  studies that may elucidate the mechanisms involved
in  metabolic aspects of zinc in obesity.
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